Original ArticleEndovascular Thrombectomy Alone versus Combined with Intravenous Thrombolysis
Introduction
Numerous studies have demonstrated the benefits of intravenous (IV) tissue plasminogen activator (tPA) for treating acute ischemic stroke, regardless of stroke subtype.1 The aim of IV tPA therapy is to recanalize the affected blood vessel and establish reperfusion.2 However, in large vessel occlusions, the efficacy of reperfusion using IV tPA alone has been suboptimal, with recanalization rates as low as 6% for occlusion of the terminal internal carotid artery.3, 4
Recently, the publication of multiple randomized controlled trials5, 6, 7, 8 convincingly demonstrated that the addition of endovascular thrombectomy (EVT) to IV tPA improved outcomes after acute ischemic stroke caused by large vessel occlusions. The design of these trials was such that the majority of patients who were treated with mechanical thrombectomy also received IV thrombolysis. However, the number of patients in these trials who did not receive previous IV tPA was very small, and thus whether previous IV tPA helps or harms patients with large vessel occlusion stroke remains unclear. Despite the potential benefits of IV tPA, its use also carries a potential risk of hemorrhagic complications,9, 10 distal embolization due to fragmentation of the thrombus, delay in subsequent EVT, and high associated costs.11
No randomized trial has directly addressed the question of whether IV tPA improves the outcomes of IV tPA–eligible patients who will eventually undergo EVT, or whether a direct EVT strategy will be equally effective. We conducted a systematic review and meta-analysis to compare the efficacy and safety of direct EVT alone versus EVT with IV tPA in adults with acute ischemic stroke.
Section snippets
Guidance
The methods and guidelines of this systematic review followed PRISMA guidelines.12, 13 We included prospective and retrospective comparative studies reporting the efficacy and safety of mechanical thrombectomy alone or combined thrombectomy with IV tPA, independent of the device used, for treating ischemic stroke in adults age ≥18 years. When institutions published duplicate studies with accumulating numbers of patients or increased durations of follow-up, only the most complete reports were
Study Selection
We identified a total of 1261 references through 6 electronic database searches (Figure 1). Although 3 randomized controlled trials6, 7 stratified results according to whether or not bridging IV tPA was administered, outcomes were reported as ORs compared with medical therapy alone. The raw data for patients in the EVT and EVT+IV tPA subgroups could not be derived, and thus these studies were excluded from the present analysis. After applying our selection criteria, we selected 12 comparative
Discussion
Despite recent randomized trials demonstrating the benefits of EVT in patients with acute anterior circulation stroke with proximal vessel occlusion,5, 6, 7, 8 whether there is any benefit to providing IV tPA treatment before EVT in this population remains unclear. In 3 of the published randomized trials comparing EVT with best medical therapy,6, 7 subgroup analysis was attempted to identify any statistically heterogeneity in treatment effect size in patients who received mechanical EVT alone
Conclusion
This meta-analysis is the first to pool direct comparative studies of patients receiving EVT alone versus those receiving EVT+IV tPA. Although we identified no statistically significant differences in favorable functional outcome, mortality rate, or complications, including symptomatic intracerebral hemorrhage, between the 2 groups, we did find a trend toward improved functional outcome in the EVT+IV tPA cohort. Further studies with larger sample sizes are warranted.
References (32)
- et al.
Is bridging with intravenous thrombolysis of any benefit in endovascular therapy for acute ischemic stroke?
World Neurosurg
(2014) - et al.
Prior IV thrombolysis facilitates mechanical thrombectomy in acute ischemic stroke
J Stroke Cerebrovasc Dis
(2015) - et al.
Is bridging necessary? A pilot study of bridging versus primary stentriever-based endovascular reperfusion in large anterior circulation strokes
J Stroke Cerebrovasc Dis
(2015) - et al.
Intra-arterial thrombectomy versus standard intravenous thrombolysis in patients with anterior circulation stroke caused by intracranial arterial occlusions: a single-center experience
J Stroke Cerebrovasc Dis
(2013) - et al.
Solitaire flow restoration device versus the Merci Retriever in patients with acute ischaemic stroke (SWIFT): a randomised, parallel-group, non-inferiority trial
Lancet
(2012) - et al.
Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial
Lancet
(2012) - et al.
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
Lancet
(2016) Tissue plasminogen activator for acute ischemic stroke
N Engl J Med
(1995)- et al.
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
Ann Neurol
(1992) - et al.
Site of arterial occlusion identified by transcranial Doppler predicts the response to intravenous thrombolysis for stroke
Stroke
(2007)
Endovascular therapy for ischemic stroke with perfusion-imaging selection
N Engl J Med
A randomized trial of intraarterial treatment for acute ischemic stroke
N Engl J Med
Thrombectomy within 8 hours after symptom onset in ischemic stroke
N Engl J Med
Stent-retriever thrombectomy after intravenous t-PA vs. t-PA alone in stroke
N Engl J Med
Thrombolysis for acute ischaemic stroke
Cochrane Database Syst Rev
Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment
JAMA Neurol
Cited by (43)
Meta-analysis of direct endovascular thrombectomy vs bridging therapy in the management of acute ischemic stroke with large vessel occlusion
2024, Clinical Neurology and NeurosurgeryClinical Implications of Preinterventional Thrombus Migration in Patients with Emergent Large Vessel Occlusion
2021, World NeurosurgeryCitation Excerpt :IVT before thrombectomy may have a role in the lysis of small thrombi along collaterals into the penumbra zone despite its limited effect on the recanalization of large vessel occlusive lesions.23 Other studies contradicted the beneficial effect of IVT in patients with ELVO eligible for thrombectomy.24-26 In such patients, preinterventional IVT may postpone the best treatment strategy (i.e., thrombectomy) particularly in drip-and-ship strategies.27
Functional outcome after mechanical thrombectomy with or without previous thrombolysis
2021, Journal of Stroke and Cerebrovascular DiseasesCitation Excerpt :In our study, the use of IVT previous to MT was not associated with better outcome at 90 days or better NIHSS at 24H after stroke, when compared to the use of MT alone. These results are in line with previous meta-analyses that found no significant differences in functional outcome after mechanical thrombectomy alone versus combined therapy with previous IVT.25,26 Also, a recently published trial comparing endovascular thrombectomy with or without intravenous Alteplase in acute stroke showed no benefit in the use of thrombolysis previous to MT regarding functional outcome.27
Conflict of interest statement: The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Supplementary digital content available online.